Expertise in

conditions

Jean-david D. Bouaziz

Paris, FR

Expertise in

conditions

Paris, FR

Overview

Jean-david Bouaziz practices practicing medicine in Paris, France.

Bouaziz is highly rated in 29 conditions, according to our data. Their clinical expertise encompasses Scleredema, Papular Mucinosis, Scleromyxedema, Balanitis, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 214 peer reviewed articles and participating in 5 clinical trials.

Locations

Paris, France

Other Locations

Creteil, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid

Enrollment Status: Active_not_recruiting

Publish Date: June 10, 2026

Intervention Type: Drug

Study Drugs: Rituximab, Cyclophosphamide

Study Phase: Phase 3

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)

Enrollment Status: Completed

Publish Date: November 05, 2025

Intervention Type: Biological

Study Drug: Lebrikizumab

Study Phase: Phase 3

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis

Enrollment Status: Completed

Publish Date: September 03, 2024

Intervention Type: Drug

Study Drug: Baricitinib

Study Phase: Phase 3

A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis

Enrollment Status: Completed

Publish Date: November 30, 2022

Intervention Type: Biological, Other

Study Drug: Lebrikizumab

Study Phase: Phase 3

A Phase IIa, Single Blind, Randomized, Study to Evaluate the Safety, the Immunogenicity, and the Clinical and Biological Efficacy of IFNα-Kinoid (IFN-K) in Adult Subjects With Dermatomyositis

Enrollment Status: Withdrawn

Publish Date: January 03, 2020

Intervention Type: Other, Biological

Study Phase: Phase 2

View 4 Less Clinical Trials

214 Total Publications

Increased risk of cutaneous lupus erythematosus flare during the late menopausal transition: A retrospective study of 64 women.

Journal: JAAD international

Published: July 12, 2026

View All 214 Publications

Frequently Asked Questions about Jean-david D. Bouaziz

Is Jean-david D. Bouaziz a top-rated expert for Scleredema?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-david D. Bouaziz is classified as an Elite expert for Scleredema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-david D. Bouaziz participate in research or clinical trials?

Yes. Jean-david D. Bouaziz has published 214 articles and abstracts on conditions like Scleredema. You can view a list of Jean-david D. Bouaziz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bouaziz's expertise for a condition

ConditionClose